| Holdings |
Net Asset(%) |
| Sun Pharmaceutical Industries Limited |
11.76 |
| DIVI LABORATORIES LTD |
8.23 |
| Glenmark Pharmaceuticals Limited |
7.12 |
| J B Chemicals and Pharma Ltd |
6.39 |
| Apollo Hospitals Enterprise Limited |
5.93 |
| Lupin Limited |
4.57 |
| Dr Reddys Laboratories Limited |
4.44 |
| Aurobindo Pharma Limited |
4.22 |
| Fortis Health Care Ltd |
4.06 |
| Laurus Labs Limited |
3.70 |
| Alkem Laboratories Limited |
3.51 |
| Krishna Inst of Medical Sciences Ltd. |
3.28 |
| (5) Total outstanding exposure in derivative instruments as on April 30, 2026 is Rs. Nil. |
3.23 |
| One Source Specialty Pharma Ltd |
3.22 |
| Cipla Limited |
3.16 |
| Sai Life Sciences Limited |
3.13 |
| IPCA Laboratories Limited |
3.03 |
| Eris Lifesciences Limited |
2.96 |
| Max Healthcare Institute Limited |
2.43 |
| Dr Lal Path Labs Ltd |
1.99 |
| Gland Pharma Limited |
1.82 |
| Mankind Pharma Limited |
1.75 |
| Narayana Hrudalaya Ltd |
1.31 |
| Anthem Biosciences Limited |
1.26 |
| Biocon Limited |
1.19 |